SIRT3-PINK1-PKM2 axis prevents osteoarthritis via mitochondrial renewal and metabolic switch

Yaoge Deng1,2, Mingzhuang Hou1,2, Yubin Wu1,2

  • 1Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, 215006, China.

Bone Research
|March 15, 2025
PubMed

Insights

This study reveals how mitochondrial quality control, involving PTEN-induced putative kinase 1 (PINK1) and SIRT3, protects cartilage from osteoarthritis (OA) by enhancing energy production and removing damaged mitochondria.

Area of Science:

  • Mitochondrial biology
  • Cellular homeostasis
  • Osteoarthritis research

Background:

  • Mitochondrial dysfunction and impaired mitophagy are implicated in osteoarthritis (OA).
  • The precise mechanisms regulating mitochondrial renewal and energy metabolism in chondrocytes during OA remain unclear.

Purpose of the Study:

  • To elucidate the role of the SIRT3-PINK1-PKM2 signaling axis in maintaining chondrocyte function and preventing cartilage degeneration in OA.
  • To investigate how mitochondrial homeostasis is regulated through mitophagy and metabolic reprogramming.

Main Methods:

  • Analysis of mitochondrial damage and mitophagy in OA chondrocytes.
  • Genetic manipulation of PINK1 and SIRT3 expression in cellular and animal models.
  • Investigation of protein-protein interactions and phosphorylation events (PINK1-PKM2).
  • Assessment of metabolic shifts and energy production.
  • Evaluation of joint integrity and motor function in a double-knockout mouse model.

Main Results:

  • OA chondrocytes exhibit mitochondrial damage and defective mitophagy.
  • Overexpression of PTEN-induced putative kinase 1 (PINK1) protected against cartilage degeneration by enhancing mitophagy.
  • PINK1 knockout exacerbated cartilage damage due to impaired mitophagy.
  • SIRT3 deacetylated PINK1, promoting mitophagy and cartilage anabolism.
  • PINK1 phosphorylated PKM2, maintaining its active tetrameric form, inhibiting nuclear translocation, and promoting a metabolic shift towards increased energy production.
  • The SIRT3-PINK1-PKM2 axis was crucial for maintaining joint structural integrity and improving motor function in mice.

Conclusions:

  • The SIRT3-PINK1-PKM2 axis is a key regulator of mitochondrial renewal and metabolic reprogramming in osteoarthritis.
  • Targeting this pathway offers a potential therapeutic strategy for preserving chondrocyte function and combating OA progression.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
9.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K